Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients

<p>Abstract</p> <p>Background</p> <p>Numerous papers have addressed the association of mutations and polymorphisms of susceptibility genes with autoimmune inflammatory disorders. We investigated whether polymorphisms that confer susceptibility to Crohn's disease co...

Full description

Bibliographic Details
Main Authors: Gaj Pawel, Habior Andrzej, Mikula Michal, Ostrowski Jerzy
Format: Article
Language:English
Published: BMC 2008-08-01
Series:BMC Medical Genetics
Online Access:http://www.biomedcentral.com/1471-2350/9/81
Description
Summary:<p>Abstract</p> <p>Background</p> <p>Numerous papers have addressed the association of mutations and polymorphisms of susceptibility genes with autoimmune inflammatory disorders. We investigated whether polymorphisms that confer susceptibility to Crohn's disease could be classified also as predisposing factors for the development of primary sclerosing cholangitis and primary biliary cirrhosis in Polish patients.</p> <p>Methods</p> <p>The study included 60 patients with CD, 77 patients with PSC, of which 61 exhibited IBD (40 UC, 8 CD, and 13 indeterminate colitis), and 144 patients with PBC. All the patients were screened against Crohn's disease associating genetic polymorphisms.</p> <p>The polymorphisms were chosen according to previously confirmed evidence for association with Crohn's disease, including Pro268Ser, Arg702Trp, Gly908Arg and 1007fs in <it>NOD2/CARD15</it>, Leu503Phe/-207G>C in <it>SLC22A4/OCTN1</it>/<it>SLC22A5/OCTN2</it>, Arg30Gln in <it>DLG5</it>, Thr300Ala in <it>ATG16L1</it>, and Arg381Gln, His3Gln and exon-3'UTR in <it>IL23R</it>. Genotyping was carried out using TaqMan SNP genotyping assays.</p> <p>Results</p> <p>We confirmed a strong association between three <it>NOD2/CARD15 </it>gene variants (Pro268Ser, OR = 2.52, 95% CI = 1.34 – 4.75); (Arg702Trp, OR = 6.65, 95% CI = 1.99 – 22.17); (1007fs, OR = 9.59, 95% CI = 3.94 – 23.29), and a weak association between both the protective <it>OCTN1/OCTN2 </it>CC haplotype (OR = 0.28, 95% CI = 0.08 – 0.94), and a variant of <it>ATG16L1 </it>gene (Thr300Ala, OR = 0.468, 95% CI = 0.24 – 0.90) with Crohn's disease. In contrast, none of the polymorphisms exhibited association with susceptibility to primary sclerosing cholangitis and primary biliary cirrhosis, including a group of primary sclerosing cholangitis patients with concurrent IBD.</p> <p>Conclusion</p> <p>Although the clinical data indicate non-random co-occurrence of inflammatory bowel disease and primary sclerosing cholangitis, consistently with the previously published studies, no genetic association was found between the genetic variants predisposing to Crohn's disease and hepatobiliary autoimmune disorders. However, since estimation of genetic variant disproportion is limited by sample size, these negative results may also indicate that eventually shared genetic predispositions are too little to be captured by small patient groups.</p>
ISSN:1471-2350